^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)

i
Other names: MTRR, 5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase, Methionine Synthase Reductase, CblE, Aquacobalamin Reductase, AqCbl Reductase, MSR, [Methionine Synthase]-Cobalamin Methyltransferase (Cob(II)Alamin Reducing), Methionine Synthase Reductase, Mitochondrial
Associations
Trials
4ms
Association of folate metabolism-related enzymes (MTHFR, MYD88, and TP53) and their single nucleotide polymorphisms with breast cancer susceptibility in women from Southwest China: a Bayesian network approach. (PubMed, Front Oncol)
External validation further demonstrated a breast cancer prevalence of 70%, underscoring the robustness of the model. Interactions among the TP53, MYD88, and folate metabolism-related genes (MTHFR, MTR, and MTRR) may play a critical role in breast cancer susceptibility.
Journal
|
TP53 (Tumor protein P53) • MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
6ms
Quantitative assessment of the associations between MTR and MTRR gene polymorphisms and glioma risk. (PubMed, Discov Oncol)
In conclusion, our study indicates that the MTRR rs1801394 polymorphism serves as a protective factor in India populations but does not affect glioma risk in Caucasian population and Chinese population, which can be used as biomarkers for predicting glioma risk and can serve as targets for personalized treatments of glioma.
Journal
|
MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
9ms
Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer. (PubMed, Cancer Res)
The remaining genes were "GC favored" and showed high heterogeneity in GC. These findings illuminate the genomic evolution from IM to IGC or DGC, providing insights that could guide precancerous lesion surveillance and early prevention strategies.
Journal • Tumor mutational burden
|
TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • TMB (Tumor Mutational Burden) • CDH1 (Cadherin 1) • BMP6 (Bone Morphogenetic Protein 6) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase) • MUC6 (Mucin 6)
|
TP53 mutation • TMB-H
1year
Methionine Synthase Reductase A66G Variant in Pediatric Acute Lymphoblastic Leukemia Patients. (PubMed, J Hematol)
The risk of acute lymphoblastic leukemia and MTRR genotypes, on the other hand, exhibited a correlation that was not statistically significant (P = 0.082). The study's findings showed that among pediatric ALL patients, the MTRR A66G polymorphism was not linked to an increased risk of ALL.
Journal
|
MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
over1year
Genetic variants in folate metabolism-related genes, serum folate and hepatocellular carcinoma survival: the Guangdong Liver Cancer Cohort study. (PubMed, Br J Nutr)
Furthermore, we observed significant interactions on both multiplicative and additive scales between serum folate levels and MTRR rs1801394 polymorphism. Carrying the variant G allele of the MTRR rs1801394 is associated with better HCC prognosis and may enhance the favourable association between higher serum folate levels and improved survival among HCC patients.
Journal
|
MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
over1year
Interrelationships among MTHFR gene polymorphisms, MTRR gene polymorphisms, and HBV gene BCP 1762/1764 mutations with disease progression in Chronic hepatitis B virus infection patients. (PubMed, Nucleosides Nucleotides Nucleic Acids)
Single difference of MTHFR C677T, MTHFR A1298C and MTRR A66G gene polymorphisms may have little effect on the disease progression in patients with chronic HBV infection. MTHFR 677CT + TT, MTRR 66AG + GG and MTHFR 1298AA genotype combined with HBV gene BCP region 1762/1764 mutation may be closely related to the occurrence and development of hepatitis B liver cancer.
Journal
|
MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
|
MTHFR C677T
over1year
New P3 trial • Head-to-Head
|
MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
|
MTHFR C677T
almost2years
Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate. (PubMed, Sci Rep)
Patients who exceeded the MTX threshold levels at 24 h after the dose had a significantly higher risk of renal toxicity (OR (95%CI) = 6.818 (2.350-19.782), p < 0.001). Multivariate logistic regression analysis with a generalized estimated equation revealed hypertension and age as independent predictors of increased MTX levels at 24 h after the given dose.
Journal
|
MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
|
methotrexate
almost2years
MTHFR and MTRR gene polymorphisms in patients with chronic hepatitis B virus infections in Zigong, Sichuan Province. (PubMed, Ann Hum Biol)
The distributions of MTHFR and MRRR genetic polymorphisms in the population with HBV infections in Zigong, Sichuan Province did not differ in age and sex. The MTHFR and MRRR genetic polymorphisms were comparable between the CHB, LC, and PLC groups.
Journal
|
MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
|
MTHFR C677T
almost2years
Interactions between vitamin B2, the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms, and colorectal cancer risk in a Korean population. (PubMed, Epidemiol Health)
The MTRR rs1801394 and MTR rs1805087 genetic polymorphisms may modify the association between vitamin B2 and CRC risk, particularly in men. However, further studies are warranted to confirm these interaction.
Journal
|
MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
over2years
Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study. (PubMed, BMC Cancer)
The information on metabolites and SNPs of the folate and methionine cycle will help predict the toxicities and efficacies of pemetrexed.
Observational data • Journal
|
MTHFR (Methylenetetrahydrofolate Reductase) • MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)
|
Avastin (bevacizumab) • pemetrexed
almost3years
Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer. (PubMed, Asian Pac J Cancer Prev)
In conclusion, MTRR c.66A>G and c.524C>T substitutions showed a joint effect with the other associated risk factors. Further studies with a greater number of subjects of different ethnicity and polymorphisms are recommended for the better understanding urinary bladder cancer etiology and to screen the population who are at higher risk of developing urinary bladder cancer.
Journal
|
MTRR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase Reductase)